Study of the Effect of Diquafosol Tetrasodium Ophthalmic Solution, 2% Versus Placebo in Dry Eye Subjects (P08634)

Launched by MERCK SHARP & DOHME LLC · Jan 23, 2008

Keywords

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Provide written informed consent prior to any study procedures being performed.
• • Have a best corrected visual acuity (BCVAof +0.7 or better.
• • Have a history of dry eye (keratoconjunctivitis sicca) in both eyes
• • Have ongoing dry eye disease, in the same qualifying eye or both eyes.
• Exclusion Criteria:
• • Have previously had LASIK refractive surgery.
• • Use of topical ophthalmic medications, preps, gels and lid scrubs during study.
• • Have had penetrating intraocular surgery in the past 90 days.
• • Have had other ocular surface surgery (e.g., refractive, pterygium) within the past year.
• • Have a diagnosis of an on-going ocular infection, clinically significant blepharitis, lid margin inflammation, Stevens-Johnson syndrome or pemphigoid.
• • Any serious ocular systemic disease or uncontrolled medical condition.
• • Exposure to any investigational drug within 30 days of study start.